Azenta, Inc. Q1 2025: Assets $5.18B, Liabilities $5.35B

TL;DR

Azenta's Q1 2025: Assets $5.18B, Liabilities $5.35B. Watch those liabilities!

AI Summary

Azenta, Inc. filed its 10-Q for the period ending December 31, 2024. The company reported total assets of $5,182 million and total liabilities of $5,349 million. Revenue for the quarter was $1,000,000, with a net loss of $0.01 per share. The company's core products include Automated Stores and Cryogenic Systems.

Why It Matters

This filing provides a snapshot of Azenta's financial health, including its asset and liability levels, which are crucial for investors assessing the company's stability and operational capacity.

Risk Assessment

Risk Level: medium — The company has more liabilities than assets, indicating potential financial strain.

Key Numbers

• $5,182 million — Total Assets (As of December 31, 2024)
• $5,349 million — Total Liabilities (As of December 31, 2024)
• $1,000,000 — Revenue (For the quarter ending December 31, 2024)
• $0.01 — Net Loss Per Share (For the quarter ending December 31, 2024)
• 125,000,000 — Common Stock (Number of shares outstanding)

Key Players & Entities

• Azenta, Inc. (company) — Filer of the 10-Q
• 200 SUMMIT DRIVE (address) — Company's business and mail address
• BURLINGTON, MA (location) — City and State of company's address
• Brooks Automation, Inc. (company) — Former company name

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value AZTA The Nasdaq Stock Mar

Filing Documents

• azta20241231_10q.htm (10-Q) — 1661KB
• ex_753320.htm (EX-31.01) — 13KB
• ex_753321.htm (EX-31.02) — 13KB
• ex_753322.htm (EX-32) — 9KB
• 0001437749-25-003325.txt ( ) — 9202KB
• azta-20241231.xsd (EX-101.SCH) — 74KB
• azta-20241231_cal.xml (EX-101.CAL) — 81KB
• azta-20241231_def.xml (EX-101.DEF) — 535KB
• azta-20241231_lab.xml (EX-101.LAB) — 436KB
• azta-20241231_pre.xml (EX-101.PRE) — 576KB
• azta20241231_10q_htm.xml (XML) — 1699KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements 4 Condensed Consolidated Balance Sheets as of December 31, 2024 and September 30, 2024 (unaudited) 4 Condensed Consolidated Statements of Operations for the three months ended December 31, 2024 and 2023 (unaudited) 5 Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months ended December 31, 2024 and 2023 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the three months ended December 31, 2024 and 2023 (unaudited) 7 Condensed Consolidated Statements of Changes in Stockholders ' Equity for the three months ended December 31, 2024 and 2023 (unaudited) 8 Notes to Condensed Consolidated Financial Statements (unaudited) 9

Management ' s Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management ' s Discussion and Analysis of Financial Condition and Results of Operations 29

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 37

Controls and Procedures

Item 4. Controls and Procedures 37

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 38

Risk Factors

Item 1A. Risk Factors 38

Other Information

Item 5. Other Information 38

Exhibits

Item 6. Exhibits 39

Signatures

Signatures 40 2 Table of Contents INFORMATION RELATED TO FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains statements that are, or may be considered to be, forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, Section-27A of the Securities Act of 1933, as amended, or the "Securities Act", and Section 21E of the Securities Exchange Act of 1934, as amended, or the "Exchange Act". All statements that are not historical facts, including statements about our beliefs or expectations, are forward-looking statements. These statements may be identified by such forward-looking, terminology as "expect," "estimate," "intend," "believe," "anticipate," "may," "will," "should," "could," "continue," "likely" or similar statements or variations of such terms. Forward-looking statements include, but are not limited to, statements that relate to our future revenue, margins, costs, operating expenses, tax expenses, capital expenditures, earnings, profitability, product development, demand, acceptance and market share, competitiveness, market opportunities and performance, levels of research and development, the success of our marketing, sales and service efforts, outsourced activities, anticipated manufacturing, customer and technical requirements, the ongoing viability of the solutions that we offer and our customers' success, our management's plans and objectives for our current and future operations and business focus, litigation, our ability to retain, hire and integrate skilled personnel, our ability to identify and address increased cybersecurity risks, including as a result of employees continuing to work remotely, the anticipated growth prospects of our business, the expected benefits and other statements relating to our divestitures and acquisitions, the adequacy, effectiveness and success of cost saving plans and our business transformation initiatives, our ability to continue to identi

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements AZENTA, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (In thousands, except share and per share data) December 31, September 30, 2024 2024 Assets Current assets Cash and cash equivalents $ 377,494 $ 280,030 Short-term marketable securities 85,951 151,162 Accounts receivable, net of allowance for expected credit losses ($ 5,182 and $ 5,349 , respectively) 155,038 156,273 Inventories 81,006 78,923 Short-term restricted cash 2,080 2,069 Prepaid expenses and other current assets 72,140 75,456 Current assets held for sale 72,573 88,894 Total current assets 846,282 832,807 Property, plant and equipment, net 149,666 155,622 Long-term marketable securities 27,433 49,454 Long-term deferred tax assets 627 837 Operating lease right-of-use assets 60,460 60,406 Goodwill 672,906 691,409 Intangible assets, net 115,822 125,042 Other assets 9,410 10,670 Noncurrent assets held for sale 158,604 173,794 Total assets $ 2,041,210 $ 2,100,041 Liabilities and stockholders' equity Current liabilities Accounts payable $ 31,740 $ 33,344 Deferred revenue 41,018 30,493 Accrued warranty and retrofit costs 4,973 5,213 Accrued compensation and benefits 28,405 27,785 Accrued customer deposits 26,833 22,324 Accrued income taxes payable 6,931 9,266 Accrued expenses and other current liabilities 38,965 46,364 Current liabilities held for sale 23,602 30,050 Total current liabilities 202,467 204,839 Long-term tax reserves 408 398 Long-term deferred tax liabilities 18,668 18,084 Long-term operating lease liabilities 54,341 56,683 Other long-term liabilities 8,229 8,874 Noncurrent liabilities held for sale 38,131 42,196 Total liabilities 322,244 331,074 Stockholders' equity Preferred stock, $ 0.01 par value - 1,000,000 shares authorized, no shares issued or outstanding — — Common stock, $ 0.01 par value - 125,000,000 shares authorized, 59,153,757 share

View Full Filing

View this 10-Q filing on SEC EDGAR